Natural killer cells: Frequency, phenotype and function in healthy cats

Veterinary Immunology and Immunopathology

Volumn 150, Issue 1-2, 2012, Pages 69-78

  Vermeulen, Ben L ^a   Devriendt, Bert ^a   Olyslaegers, Dominique A ^a   Dedeurwaerder, Annelike ^a   Desmarets, Lowiese M ^a   Grauwet, Korneel L ^a   Favoreel, Herman W ^a   Dewerchin, Hannah L ^a   Nauwynck, Hans J ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Cat; Innate immunity; K562; Natural killer cells; Phenotype; Quantification

Indexed keywords

CD11B ANTIGEN; INTERLEUKIN 2; L SELECTIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CAT; CELL STRAIN K 562; CYTOTOXICITY; GENETIC CONSERVATION; LYMPH NODE; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MESENTERY; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE;

ANIMALS; ANTIGENS, CD11B; CATS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; IMMUNOPHENOTYPING; K562 CELLS; KILLER CELLS, NATURAL; L-SELECTIN; LYMPH NODES; MALE; MICROSCOPY, CONFOCAL; SPLEEN;

BOVINAE; FELIDAE; MURINAE; OVIS;

EID: 84867332381     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.08.010     Document Type: Article

References (55)

1. Addison E.G., North J., Bakhsh I., Marden C., Haq S., Al-Sarraj S., Malayeri R., Wickremasinghe R.G., Davies J.K., Lowdell M.W. Ligation of CD8 alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity. Immunology 2005, 116:354-361.
2. Alter G., Teigen N., Ahern R., Streeck H., Meier A., Rosenberg E.S., Altfeld M. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J. Infect. Dis. 2007, 195:1452-1460.
3. Babcock G.F., Phillips J.H. Human Nk cells - light and electron-microscopic characteristics. Surv. Immunol. Res. 1983, 2:88-101.
4. Bajenoff M., Breart B., Huang A.Y.C., Qi H., Cazareth J., Braud V.M., Germain R.N., Glaichenhaus N. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J. Exp. Med. 2006, 203:619-631.
5. Berzins S.P., Smyth M.J., Baxter A.G. Presumed guilty: natural killer T cell defects and human disease. Nat. Rev. Immunol. 2011, 11:131-142.
6. Blum K.S., Pabst R. Lymphocyte numbers and subsets in the human blood - do they mirror the situation in all organs?. Immunol. Lett. 2007, 108:45-51.
7. Boysen P., Gunnes G., Pende D., Valheim M., Storset A.K. Natural killer cells in lymph nodes of healthy calves express CD16 and show both cytotoxic and cytokine-producing properties. Dev. Comp. Immunol. 2008, 32:773-783.
8. Brandstadter J.D., Yang Y.P. Natural killer cell responses to viral infection. J. Innate Immun. 2011, 3:274-279.
9. Chiossone L., Chaix J., Fuseri N., Roth C., Vivier E., Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009, 113:5488-5496.
10. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol. 2001, 22:633-640.
11. Dalbeth N., Gundle R., Davies R.J.O., Lee Y.C.G., McMichael A.J., Callan M.F.C. CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J. Immunol. 2004, 173:6418-6426.
12. Diefenbach A., Raulet D.H. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol. Rev. 2002, 188:9-21.
13. Elhmouzi-Younes J., Boysen P., Pende D., Storset A.K., Le Vern Y., Laurent F., Drouet F. Ovine CD16(+)/CD14(-) blood lymphocytes present all the major characteristics of natural killer cells. Vet. Res. 2010, 41:4-16.
14. Evans D.L., Jasofriedmann L. Natural-killer (Nk) cells in domestic-animals - phenotype, target-cell specificity and cytokine regulation. Vet. Res. Commun. 1993, 17:429-447.
15. Fehniger T.A., Cooper M.A., Nuovo G.J., Cella M., Facchetti F., Colonna M., Caligiuri M.A. CD56(bright) natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003, 101:3052-3057.
16. Ferlazzo G., Munz C. NK cell compartments and their activation by dendritic cells. J. Immunol. 2004, 172:1333-1339.
17. Ferlazzo G., Thomas D., Lin S.L., Goodman K., Morandi B., Muller W.A., Moretta A., Munz C. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 2004, 172:1455-1462.
18. Freud A.G., Yokohama A., Becknell B., Lee M.T., Mao H.Y.C., Ferketich A.K., Caligiuri M.A. Evidence for discrete stages of human natural killer cell differentiation in vivo. J. Exp. Med. 2006, 203:1033-1043.
19. Fu B.Q., Wang F.Y., Sun R., Ling B., Tian Z.G., Wei H.M. CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. Immunology 2011, 133:350-359.
20. Gerner W., Kaser T., Saalmuller A. Porcine T lymphocytes and NK cells - an update. Dev. Comp. Immunol. 2009, 33:310-320.
21. Govaerts A. Cellular antibodies in kidney homotransplantation. J. Immunol. 1960, 85:516-522.
22. Hanlon M.A., Marr J.M., Hayes K.A., Mathes L.E., Stromberg P.C., Ringler S., Krakowka S., Lafrado L.J. Loss of neutrophil and natural killer cell function following feline immunodeficiency virus infection. Viral Immunol. 1993, 6:119-124.
23. Hayakawa Y., Smyth M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 2006, 176:1517-1524.
24. Howard K.E., Reckling S.K., Egan E.A., Dean G.A. Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats. Retrovirology 2010, 7:2-16.
25. Hu J., Starkey J.R., Prieur D.J. A lack of natural-killer cell-activity in domestic cats. Fed. Proc. 1982, 41:802.
26. Ishizaki H., Kariya Y. Road transportation stress promptly increases bovine peripheral blood absolute NK cell counts and cortisol levels. J. Vet. Med. Sci. 2010, 72:747-753.
27. Jedema I., van der Werff N.M., Barge R.M.Y., Willemze R., Falkenburg J.H.F. New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood 2004, 103:2677-2682.
28. Jondal M., Pross H. Surface markers on human B and T lymphocytes. 6. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int. J. Cancer 1975, 15:596-605.
29. Jonjic S., Babic M., Polic B., Krmpotic A. Immune evasion of natural killer cells by viruses. Curr. Opin. Immunol. 2008, 20:30-38.
30. Kaname H., Mori Y., Sumida Y., Kojima K., Kubo C., Tashiro N. Changes in the leukocyte distribution and surface expression of adhesion molecules induced by hypothalamic stimulation in the cat. Brain Behav. Immun. 2002, 16:351-367.
31. Kooistra L.H., Splitter G.A. Killer cells of feline leukemia-virus infected and feline sarcoma virus-infected transformed-cells - the role of Nk, Adcc, and invitro generated cyto-toxic cells. Cell. Immunol. 1985, 94:466-479.
32. Kuylenstierna C., Bjorkstrom N.K., Andersson S.K., Sahlstrom P., Bosnjak L., Paquin-Proulx D., Malmberg K.J., Ljunggren H.G., Moll M., Sandberg J.K. NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d. Eur. J. Immunol. 2011, 41:1913-1923.
33. Lee S., Kim J., Jang B., Hur S., Jung U., Kil K., Na B., Lee M., Choi Y., Fukui A., Gilman-Sachs A., Kwak-Kim J.Y. Fluctuation of peripheral blood T, B, and NK cells during a menstrual cycle of normal healthy women. J. Immunol. 2010, 185:756-762.
34. Mccarty J.M., Grant C.K. Feline cyto-toxic immune-mechanisms against virus-associated leukemia and fibro-sarcoma. Cell. Immunol. 1983, 81:157-168.
35. Norris S., Collins C., Doherty D.G., Smith F., McEntee G., Traynor O., Nolan N., Hegarty J., O'Farrelly C. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J. Hepatol. 1998, 28:84-90.
36. Reeves R.K., Gillis J., Wong F.E., Yu Y., Connole M., Johnson R.P. CD16(-) natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 2010, 115:4439-4446.
37. Reynolds C.W., Sharrow S.O., Ortaldo J.R., Herberman R.B. Natural-killer activity in the rat. 2. Analysis of surface-antigens on Lgl by flow-cytometry. J. Immunol. 1981, 127:2204-2208.
38. Shimojima M., Nishimura Y., Miyazawa T., Kato K., Tohya Y., Akashi H. CD56 expression in feline lymphoid cells. J. Vet. Med. Sci. 2003, 65:769-773.
39. Sivori S., Falco M., Marcenaro E., Parolini S., Biassoni R., Bottino C., Moretta L., Moretta A. Early expression of triggering receptors and regulatory role of 2134 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:4526-4531.
40. Tarazona R., Gayoso I., Alonso C., Pita M.L., Peralbo E., Casado J.G., Sánchez-Correa B., Morgado S., Solana R. NK cells in human ageing. Handbook on Immunosenescence: Basic Understanding and Clinical Applications 2009, 531-544. Springer, New York/Dordrecht. T. Fülöp (Ed.).
41. Tessmer M.S., Reilly E.C., Brossay L. Salivary gland NK cells are phenotypically and functionally unique. PLoS Pathog. 2011, 7. Article number e1001254, doi:1001210.1001371/journal.ppat.1001254.
42. Timonen T., Ortaldo J.R., Herberman R.B. Characteristics of human large granular lymphocytes and relationship to natural-killer and K-cells. J. Exp. Med. 1981, 153:569-582.
43. Tompkins M.B., Huber K., Tompkins W.A.F. Natural cell-mediated cyto-toxicity in the domestic cat - properties and specificity of effector-cells. Am. J. Vet. Res. 1983, 44:1525-1529.
44. Tompkins M.B., Pang V.F., Michaely P.A., Feinmehl R.I., Basgall E.J., Baszler T.V., Zachary J.F., Tompkins W.A. Feline cytotoxic large granular lymphocytes induced by recombinant human IL-2. J. Immunol. 1989, 143:749-754.
45. Tompkins M.B., Tompkins W.A.F. Stimulation of a cell-mediated cyto-toxic response to Felv-induced T-cell lymphomas in the cat. J. Immunol. 1985, 135:2817-2823.
46. Trinchieri G. Biology of natural-killer cells. Adv. Immunol. 1989, 47:187-376.
47. Van Kaer L. NKT cells: T lymphocytes with innate effector functions. Curr. Opin. Immunol. 2007, 19:354-364.
48. Vermeulen B.L., Gleich S.E., Dedeurwaerder A., Olyslaegers D.A., Desmarets L.M., Dewerchin H.L., Nauwynck H.J. In vitro assessment of the feline cell-mediated immune response against feline panleukopeniavirus, calicivirus and felid herpesvirus 1 using 5-bromo-2'-deoxyuridine labeling. Vet. Immunol. Immunopathol. 2012, 146:177-184.
49. von Andrian U.H., Mempel T.R. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 2003, 3:867-878.
50. West W.H., Cannon G.B., Kay H.D., Bonnard G.D., Herberman R.B. Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line - characterization of effector cells. J. Immunol. 1977, 118:355-361.
51. Westermann J., Pabst R. Distribution of lymphocyte subsets and natural-killer-cells in the human-body. Clin. Investig. 1992, 70:539-544.
52. Wood S.M., Ljunggren H.G., Bryceson Y.T. Insights into NK cell biology from human genetics and disease associations. Cell. Mol. Life Sci. 2011, 68:3479-3493.
53. Yu Y.Y., Kumar V., Bennett M. Murine natural killer cells and marrow graft rejection. Annu. Rev. Immunol. 1992, 10:189-213.
54. Zaccaro L., Falcone M.L., Silva S., Bigalli L., Cecchettini A., Giorgi F., Malvaldi G., Bendinelli M. Defective natural-killer-cell cytotoxic activity in feline immunodeficiency virus-infected cats. AIDS Res. Hum. Retroviruses 1995, 11:747-752.
55. Zhao Y., Gebhard D., English R., Sellon R., Tompkins M., Tompkins W. Enhanced expression of novel Cd57(+)Cd8(+) Lak cells from cats infected with feline immunodeficiency virus. J. Leukoc. Biol. 1995, 58:423-431.